Cargando…

The mechanism of human neural stem cell secretomes improves neuropathic pain and locomotor function in spinal cord injury rat models: through antioxidant, anti-inflammatory, anti-matrix degradation, and neurotrophic activities

BACKGROUND: Globally, spinal cord injury (SCI) results in a big burden, including 90% suffering permanent disability, and 60%–69% experiencing neuropathic pain. The main causes are oxidative stress, inflammation, and degeneration. The efficacy of the stem cell secretome is promising, but the role of...

Descripción completa

Detalles Bibliográficos
Autores principales: Semita, I Nyoman, Utomo, Dwikora Novembri, Suroto, Heri, Sudiana, I Ketut, Gandi, Parama
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Pain Society 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812698/
https://www.ncbi.nlm.nih.gov/pubmed/36549874
http://dx.doi.org/10.3344/kjp.22279
_version_ 1784863785612214272
author Semita, I Nyoman
Utomo, Dwikora Novembri
Suroto, Heri
Sudiana, I Ketut
Gandi, Parama
author_facet Semita, I Nyoman
Utomo, Dwikora Novembri
Suroto, Heri
Sudiana, I Ketut
Gandi, Parama
author_sort Semita, I Nyoman
collection PubMed
description BACKGROUND: Globally, spinal cord injury (SCI) results in a big burden, including 90% suffering permanent disability, and 60%–69% experiencing neuropathic pain. The main causes are oxidative stress, inflammation, and degeneration. The efficacy of the stem cell secretome is promising, but the role of human neural stem cell (HNSC)-secretome in neuropathic pain is unclear. This study evaluated how the mechanism of HNSC-secretome improves neuropathic pain and locomotor function in SCI rat models through antioxidant, anti-inflammatory, anti-matrix degradation, and neurotrophic activities. METHODS: A proper experimental study investigated 15 Rattus norvegicus divided into normal, control, and treatment groups (30 µL HNSC-secretome, intrathecal in the level of T10, three days post-traumatic SCI). Twenty-eight days post-injury, specimens were collected, and matrix metalloproteinase (MMP)-9, F2-Isoprostanes, tumor necrosis factor (TNF)-α, transforming growth factor (TGF)-β, and brain derived neurotrophic factor (BDNF) were analyzed. Locomotor recovery was evaluated via Basso, Beattie, and Bresnahan scores. Neuropathic pain was evaluated using the Rat Grimace Scale. RESULTS: The HNSC-secretome could improve locomotor recovery and neuropathic pain, decrease F2-Isoprostane (antioxidant), decrease MMP-9 and TNF-α (anti-inflammatory), as well as modulate TGF-β and BDNF (neurotrophic factor). Moreover, HNSC-secretomes maintain the extracellular matrix of SCI by reducing the matrix degradation effect of MMP-9 and increasing the collagen formation effect of TGF-β as a resistor of glial scar formation. CONCLUSIONS: The present study demonstrated the mechanism of HNSC-secretome in improving neuropathic pain and locomotor function in SCI through antioxidant, anti-inflammatory, anti-matrix degradation, and neurotrophic activities.
format Online
Article
Text
id pubmed-9812698
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Korean Pain Society
record_format MEDLINE/PubMed
spelling pubmed-98126982023-01-11 The mechanism of human neural stem cell secretomes improves neuropathic pain and locomotor function in spinal cord injury rat models: through antioxidant, anti-inflammatory, anti-matrix degradation, and neurotrophic activities Semita, I Nyoman Utomo, Dwikora Novembri Suroto, Heri Sudiana, I Ketut Gandi, Parama Korean J Pain Experimental Research Articles BACKGROUND: Globally, spinal cord injury (SCI) results in a big burden, including 90% suffering permanent disability, and 60%–69% experiencing neuropathic pain. The main causes are oxidative stress, inflammation, and degeneration. The efficacy of the stem cell secretome is promising, but the role of human neural stem cell (HNSC)-secretome in neuropathic pain is unclear. This study evaluated how the mechanism of HNSC-secretome improves neuropathic pain and locomotor function in SCI rat models through antioxidant, anti-inflammatory, anti-matrix degradation, and neurotrophic activities. METHODS: A proper experimental study investigated 15 Rattus norvegicus divided into normal, control, and treatment groups (30 µL HNSC-secretome, intrathecal in the level of T10, three days post-traumatic SCI). Twenty-eight days post-injury, specimens were collected, and matrix metalloproteinase (MMP)-9, F2-Isoprostanes, tumor necrosis factor (TNF)-α, transforming growth factor (TGF)-β, and brain derived neurotrophic factor (BDNF) were analyzed. Locomotor recovery was evaluated via Basso, Beattie, and Bresnahan scores. Neuropathic pain was evaluated using the Rat Grimace Scale. RESULTS: The HNSC-secretome could improve locomotor recovery and neuropathic pain, decrease F2-Isoprostane (antioxidant), decrease MMP-9 and TNF-α (anti-inflammatory), as well as modulate TGF-β and BDNF (neurotrophic factor). Moreover, HNSC-secretomes maintain the extracellular matrix of SCI by reducing the matrix degradation effect of MMP-9 and increasing the collagen formation effect of TGF-β as a resistor of glial scar formation. CONCLUSIONS: The present study demonstrated the mechanism of HNSC-secretome in improving neuropathic pain and locomotor function in SCI through antioxidant, anti-inflammatory, anti-matrix degradation, and neurotrophic activities. The Korean Pain Society 2023-01-01 2023-01-01 /pmc/articles/PMC9812698/ /pubmed/36549874 http://dx.doi.org/10.3344/kjp.22279 Text en © The Korean Pain Society, 2023 https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Experimental Research Articles
Semita, I Nyoman
Utomo, Dwikora Novembri
Suroto, Heri
Sudiana, I Ketut
Gandi, Parama
The mechanism of human neural stem cell secretomes improves neuropathic pain and locomotor function in spinal cord injury rat models: through antioxidant, anti-inflammatory, anti-matrix degradation, and neurotrophic activities
title The mechanism of human neural stem cell secretomes improves neuropathic pain and locomotor function in spinal cord injury rat models: through antioxidant, anti-inflammatory, anti-matrix degradation, and neurotrophic activities
title_full The mechanism of human neural stem cell secretomes improves neuropathic pain and locomotor function in spinal cord injury rat models: through antioxidant, anti-inflammatory, anti-matrix degradation, and neurotrophic activities
title_fullStr The mechanism of human neural stem cell secretomes improves neuropathic pain and locomotor function in spinal cord injury rat models: through antioxidant, anti-inflammatory, anti-matrix degradation, and neurotrophic activities
title_full_unstemmed The mechanism of human neural stem cell secretomes improves neuropathic pain and locomotor function in spinal cord injury rat models: through antioxidant, anti-inflammatory, anti-matrix degradation, and neurotrophic activities
title_short The mechanism of human neural stem cell secretomes improves neuropathic pain and locomotor function in spinal cord injury rat models: through antioxidant, anti-inflammatory, anti-matrix degradation, and neurotrophic activities
title_sort mechanism of human neural stem cell secretomes improves neuropathic pain and locomotor function in spinal cord injury rat models: through antioxidant, anti-inflammatory, anti-matrix degradation, and neurotrophic activities
topic Experimental Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812698/
https://www.ncbi.nlm.nih.gov/pubmed/36549874
http://dx.doi.org/10.3344/kjp.22279
work_keys_str_mv AT semitainyoman themechanismofhumanneuralstemcellsecretomesimprovesneuropathicpainandlocomotorfunctioninspinalcordinjuryratmodelsthroughantioxidantantiinflammatoryantimatrixdegradationandneurotrophicactivities
AT utomodwikoranovembri themechanismofhumanneuralstemcellsecretomesimprovesneuropathicpainandlocomotorfunctioninspinalcordinjuryratmodelsthroughantioxidantantiinflammatoryantimatrixdegradationandneurotrophicactivities
AT surotoheri themechanismofhumanneuralstemcellsecretomesimprovesneuropathicpainandlocomotorfunctioninspinalcordinjuryratmodelsthroughantioxidantantiinflammatoryantimatrixdegradationandneurotrophicactivities
AT sudianaiketut themechanismofhumanneuralstemcellsecretomesimprovesneuropathicpainandlocomotorfunctioninspinalcordinjuryratmodelsthroughantioxidantantiinflammatoryantimatrixdegradationandneurotrophicactivities
AT gandiparama themechanismofhumanneuralstemcellsecretomesimprovesneuropathicpainandlocomotorfunctioninspinalcordinjuryratmodelsthroughantioxidantantiinflammatoryantimatrixdegradationandneurotrophicactivities
AT semitainyoman mechanismofhumanneuralstemcellsecretomesimprovesneuropathicpainandlocomotorfunctioninspinalcordinjuryratmodelsthroughantioxidantantiinflammatoryantimatrixdegradationandneurotrophicactivities
AT utomodwikoranovembri mechanismofhumanneuralstemcellsecretomesimprovesneuropathicpainandlocomotorfunctioninspinalcordinjuryratmodelsthroughantioxidantantiinflammatoryantimatrixdegradationandneurotrophicactivities
AT surotoheri mechanismofhumanneuralstemcellsecretomesimprovesneuropathicpainandlocomotorfunctioninspinalcordinjuryratmodelsthroughantioxidantantiinflammatoryantimatrixdegradationandneurotrophicactivities
AT sudianaiketut mechanismofhumanneuralstemcellsecretomesimprovesneuropathicpainandlocomotorfunctioninspinalcordinjuryratmodelsthroughantioxidantantiinflammatoryantimatrixdegradationandneurotrophicactivities
AT gandiparama mechanismofhumanneuralstemcellsecretomesimprovesneuropathicpainandlocomotorfunctioninspinalcordinjuryratmodelsthroughantioxidantantiinflammatoryantimatrixdegradationandneurotrophicactivities